Allotment is out. Check your result on the Sheel Biotech SME IPO Allotment Status page.
Sheel Biotech SME logo

Sheel Biotech SME IPO Subscription Status

|Listed

Sheel Biotech SME IPO closed on 3 October 2025 with an overall subscription of 15.97x based on shares applied. QIB demand came in at 19.73x, NII at 26.29x, and retail at 9.57x.

Allotment will be finalised on 6 October 2025. The stock is scheduled to list on NSE and BSE on 8 October 2025.

Issue Price

Rs 63.00

GMP Today

Rs 16.00 (+25.40%)

Overall Subscription

15.97x

Issue Size

₹32.31 Cr

Allotment Date

6 Oct 2025

Listing Date

8 Oct 2025

Sheel Biotech SME IPO Subscription by Amount

Category-wise subscription based on amount applied at issue price Rs 63.00

CategoryAmount OfferedAmount AppliedSubscription
QIBRs 6.46 CrRs 127.54 Cr19.73x
FII-Rs 37.43 Cr-
DFI---
Mutual Funds---
Other-Rs 90.10 Cr-
NIIRs 4.88 CrRs 128.22 Cr26.29x
bNII (above Rs 10L)Rs 3.25 CrRs 104.55 Cr32.16x
Corporate-Rs 21.87 Cr-
Individual-Rs 81.69 Cr-
Other-Rs 99.54 L-
sNII (Rs 2L to Rs 10L)Rs 1.63 CrRs 23.66 Cr14.56x
Corporate-Rs 35.28 L-
Individual-Rs 22.97 Cr-
Other-Rs 34.02 L-
INDRs 11.37 CrRs 108.74 Cr9.57x
TotalRs 22.71 CrRs 364.49 Cr16.05x

Sheel Biotech SME IPO Subscription by Applications

Category-wise subscription based on applications received

CategoryApplications OfferedApplications ReceivedSubscription
QIB513180.04x
FII-5-
DFI---
Mutual Funds---
Other-13-
NII1291,36310.57x
bNII (above Rs 10L)867618.85x
Corporate-16-
Individual-736-
Other-9-
sNII (Rs 2L to Rs 10L)4360214.00x
Corporate-9-
Individual-584-
Other-9-
IND4514,3159.57x
Total1,0935,6965.21x

What Do These Subscription Numbers Mean?

A subscription of 15.97x by shares means the IPO received bids for 16 times the shares reserved. Allotment odds depend on application count in each category, not share volume.

Here is what each category number tells you:

QIB at 19.73x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 19.73x, it reflects serious institutional conviction.

NII at 10.57x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 8.85x and sNII at 14.00x by applications. Share subscription was 26.29x. Allotment uses application count, not share volume.

At 9.57x subscription by applications, approximately 1 in 10 retail applicants can expect an allotment (~10% per application). Retail allotment is done by lottery when oversubscribed.

Sheel Biotech SME IPO Allotment Chances

Allotment odds below use application subscription (number of bids received), not share or amount subscribed.

Retail (IND)

  • Application subscription: 9.57x.
  • Allotment odds: about 1 in 10 (~10% chance per application).
  • Method: Lottery. If allotted, you receive at least one lot.
  • One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.

SHNI (Rs 2 lakh to Rs 10 lakh)

  • Application subscription: 14.00x.
  • Allotment odds: about 1 in 14 for a minimum-lot application (~7% of the applied lot on average).
  • Method: Proportional. Shares allotted are based on your bid size, not a lottery.
  • Share subscription was 14.56x. Allotment uses application count, not share volume.

BHNI (above Rs 10 lakh)

  • Application subscription: 8.85x.
  • Allotment odds: about 1 in 9 for a minimum-lot application (~11% of the applied lot on average).
  • Method: Proportional. Shares allotted are based on your bid size, not a lottery.
  • Share subscription was 32.16x. Allotment uses application count, not share volume.

Check the Sheel Biotech SME IPO Allotment Status page from 6 October 2025 for your allotment result.

Sheel Biotech SME IPO GMP After Subscription

GMP for Sheel Biotech SME stands at Rs 16.00 today, giving an estimated listing price of Rs 79.00 per share.

A subscription of 15.97x combined with a GMP of 25.40% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.

Track live GMP on the Sheel Biotech SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.

Sheel Biotech SME IPO Day-wise Subscription

DayQIBNIIRetailOverall
Day 1 - 30 Sept 20250.00x0.13x0.08x0.07x
Day 2 - 1 Oct 20250.02x0.15x0.52x0.30x
Day 3 - 3 Oct 202519.73x25.92x9.56x15.97x

Sheel Biotech SME IPO Key Dates

EventDate
IPO Open Date30 September 2025
IPO Close Date3 October 2025
Allotment Date6 October 2025
Refund Initiation7 October 2025
Share Credit to Demat7 October 2025
Listing Date8 October 2025
Minimum InvestmentRs 2,52,000.00
Lot Size2000 shares

About Sheel Biotech SME

No company information available

Understanding Subscription Categories

QIB - Qualified Institutional Buyers

Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.

NII - Non-Institutional Investors

High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.

IND - Individual Investors

Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.

Advertisement

Sheel Biotech SME IPO Subscription FAQs

What is Sheel Biotech SME IPO subscription status today?

Sheel Biotech SME IPO subscription closed on 3 October 2025 with overall subscription of 15.97x (by shares) as of 27 June 2026, 2:01 AM IST. QIB 19.73x, NII 10.57x, IND 9.57x.

What is the overall subscription of Sheel Biotech SME IPO?

Sheel Biotech SME IPO is subscribed 15.97x overall by shares at close on 3 October 2025. QIB 19.73x, NII 10.57x, and IND 9.57x.

What is Sheel Biotech SME IPO QIB subscription?

Sheel Biotech SME IPO QIB (Qualified Institutional Buyers) subscription is 19.73x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.

What is Sheel Biotech SME IPO IND subscription?

Sheel Biotech SME IPO IND subscription is 9.57x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.

What is Sheel Biotech SME IPO NII subscription?

Sheel Biotech SME IPO NII (Non-Institutional Investors) subscription is 10.57x by applications. NII covers bids above Rs 2 lakh.

What are allotment chances in Sheel Biotech SME IPO for retail?

At 9.57x subscription by applications, approximately 1 in 10 retail applicants can expect an allotment (~10% per application). Allotment is done by lottery.

When is Sheel Biotech SME IPO allotment date?

Sheel Biotech SME IPO allotment date is 6 October 2025. Check Sheel Biotech SME IPO Allotment Status on IPOwiz from that day using your PAN.

When does Sheel Biotech SME IPO subscription close?

Sheel Biotech SME IPO subscription closed on 3 October 2025. No new applications are accepted after the close.

What is Sheel Biotech SME IPO GMP today?

Sheel Biotech SME IPO GMP is ₹16 today (+25.40% over issue price ₹63). See live GMP on the Sheel Biotech SME IPO GMP Today page.

What is Sheel Biotech SME IPO issue price and lot size?

Sheel Biotech SME IPO issue price is ₹63 per share. Lot size is 2000 shares. Minimum investment is ₹2,52,000 per lot (minimum 2 lots for SME). Issue size: ₹32.31 Cr.

When is Sheel Biotech SME IPO listing date?

Sheel Biotech SME IPO listing date is 8 October 2025 on NSE and BSE. Allotment is on 6 October 2025.

How does subscription affect Sheel Biotech SME IPO allotment?

Allotment odds in Sheel Biotech SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII proportional allotment at 10.57x by applications means roughly 1 in 11 for minimum-lot bids; bNII at 8.85x (~1 in 9). At 15.97x overall, competition is high.

For allotment results from 6 October 2025, visit the Sheel Biotech SME IPO Allotment Status page. For listing day updates on 8 October 2025, download the IPOwiz App.

Reviewed by Dinesh Agrawal

15+ years in Indian capital markets and IPO research. Subscription data verified before publish.